Bitterman Kevin sold IRON
August 5, 2025 · Form 4 insider transaction
Bitterman Kevin sold 395 shares of Disc Medicine, Inc. at $60.95 per share, a transaction worth $24.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
Shares were sold pursuant to a Rule 10b5-1 trading plan dated January 31, 2025.; These shares are held by Atlas Venture Opportunity Fund I, LP ("Opportunity I"). The general partner of Opportunity I is Atlas Venture Associates Opportunity I, LP ("Associates I"). Atlas Venture Associates Opportunity I, LLC ("Associates I LLC") is the general partner of Associates I. The Reporting Person is a member of Associates I LLC and disclaims beneficial ownership of such securities held by Opportunity I, except to the extent of his pecuniary interest therein, if any.